Marzuk PM, Tardiff K, Leon AC, et al. Ambient temperature and mortality from unintentional cocaine overdose. JAMA. 1998 Jun 10;279(22):1795-800.
Lange RA, Cigarroa RG, Yancy CW, et al. Cocaine-induced coronary artery vasoconstriction. N Engl J Med. 1989 Dec 7;321(23):1557-62.
Hollander JE, Hoffman RS, Gennis P, et al. Prospective multi-center evaluation of cocaine-associated chest pain. Acad Emerg Med. 1994 Jul-Aug;1(4):330-9.
Parker RB, Perry GY, Horan LG, et al. Comparative effects of sodium bicarbonate and sodium chloride on reversing cocaine-induced changes in the electrocardiogram. J Cardiovasc Pharmacol. 1999 Dec;34(6):864-9.
Winecoff AP, Hariman RJ, Grawe JJ, et al. Reversal of the electrocardiographic effects of cocaine by lidocaine. Part 1: comparison with sodium bicarbonate and quinidine. Pharmacotherapy. 1994 Nov-Dec;14(6):698-703.
Armstrong LE, Crago AE, Adams R, et al. Whole-body cooling of hyperthermic runners: comparison of two field therapies. Am J Emerg Med. 1996 Jul;14(4):355-8.
Catravas JD, Waters IW. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Ther. 1981 May;217(2):350-6.
Traub SJ, Hoffman RS, Nelson LS. Body packing: the internal concealment of illicit drugs. N Engl J Med. 2003 Dec 25;349(26):2519-26.
Kolodgie FD, Wilson PS, Mergner WJ, et al. Cocaine-induced increase in the permeability function of human vascular endothelial cell monolayers. Exp Mol Pathol. 1999 Jun;66(2):109-22.
1. United Nations Office on Drugs and Crime. Global illicit drug trends: executive summary. Jun 2003 [internet publication].
2. Haasen C, Prinzleve M, Zurhold H, et al. Cocaine use in Europe - a multi-centre study. Eur Addict Res. 2004;10(4):139-46.
3. US Department of Health and Human Services: Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2005 national survey on drug use and health: national findings (Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194). Sep 2006 [internet publication].
4. Kaye S, Darke S. Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia. Addiction. 2004 Oct;99(10):1315-22.
5. Marzuk PM, Tardiff K, Leon AC, et al. Ambient temperature and mortality from unintentional cocaine overdose. JAMA. 1998 Jun 10;279(22):1795-800.
6. Lai MW, Klein-Schwartz W, Rodgers GC, et al. 2005 annual report of the American Association of Poison Control Centers' national poisoning and exposure database. Clin Toxicol (Phila). 2006;44(6-7):803-932.
7. Bernstein KT, Bucciarelli A, Piper TM, et al. Cocaine and opiate-related fatal overdose in New York City 1990-2000. BMC Public Health. 2007 Mar 9;7:31.
8. Tardiff K, Marzuk PM, Leon AC, et al. Accidental fatal drug overdoses in New York City: 1990-1992. Am J Drug Alcohol Abuse. 1996 May;22(2):135-46.
9. Wood DM, Dargan PI, Hoffman RS. Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction. Clin Toxicol (Phila). 2009 Jan;47(1):14-23.
10. Temesy-Armos PN, Fraker TD, Brewster PS, et al. The effects of cocaine on cardiac electrophysiology in conscious dogs. J Cardiovasc Pharmacol. 1992 Jun;19(6):883-91.
11. Ramirez FD, Femenía F, Simpson CS, et al. Electrocardiographic findings associated with cocaine use in humans: a systematic review. Expert Rev Cardiovasc Ther. 2012 Jan;10(1):105-27.
12. Leshner A. Molecular mechanisms of cocaine addiction. N Engl J Med. 1996 Jul 11;335(2):128-9.
13. Volkow ND, Wang GJ, Fischman MW, et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature. 1997 Apr 24;386(6627):827-30.
14. Lange RA, Cigarroa RG, Yancy CW, et al. Cocaine-induced coronary artery vasoconstriction. N Engl J Med. 1989 Dec 7;321(23):1557-62.
15. Marzuk PM, Tardiff K, Leon AC, et al. Poverty and fatal accidental drug overdoses of cocaine and opiates in New York City: an ecological study. Am J Drug Alcohol Abuse. 1997 May;23(2):221-8.
16. Hoffman RS, Henry GC, Howland MA, et al. Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Ann Emerg Med. 1992 Mar;21(3):247-53.
17. Hollander JE, Hoffman RS, Gennis P, et al. Prospective multi-center evaluation of cocaine-associated chest pain. Acad Emerg Med. 1994 Jul-Aug;1(4):330-9.
18. Levine SR, Brust JC, Futrell N, et al. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med. 1990 Sep 13;323(11):699-704.
19. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984 Oct 12;252(14):1905-7.
20. Seltzer ML. The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry. 1971 Jun;127(12):1653-8.
21. Sawka AM, Jaeschke R, Singh RJ, et al. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab. 2003 Feb;88(2):553-8.
22. Parker RB, Perry GY, Horan LG, et al. Comparative effects of sodium bicarbonate and sodium chloride on reversing cocaine-induced changes in the electrocardiogram. J Cardiovasc Pharmacol. 1999 Dec;34(6):864-9.
23. Winecoff AP, Hariman RJ, Grawe JJ, et al. Reversal of the electrocardiographic effects of cocaine by lidocaine. Part 1: comparison with sodium bicarbonate and quinidine. Pharmacotherapy. 1994 Nov-Dec;14(6):698-703.
24. Phillips K, Luk A, Soor GS, et al. Cocaine cardiotoxicity: A review of the pathophysiology, pathology, and treatment options . Am J Cardiovasc Drugs. 2009;9(3):177-96.
25. Armstrong LE, Crago AE, Adams R, et al. Whole-body cooling of hyperthermic runners: comparison of two field therapies. Am J Emerg Med. 1996 Jul;14(4):355-8.
26. Jatlow P, Barash PG, Van Dyke C, et al. Cocaine and succinylcholine sensitivity: a new caution. Anesth Analg. 1979 May-Jun;58(3):235-8.
27. Nelson LS, Olsen D. Chapter 38: opioids. In: Hoffman RS, Nelson LS, Goldfrank LR, et al, eds. Goldfrank's toxicologic emergencies. 9th ed. New York, NY: McGraw-Hill; 2011.
28. Catravas JD, Waters IW. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Ther. 1981 May;217(2):350-6.
29. Shih RD, Hollander JE, Burstein JL, et al. Clinical safety of lidocaine in patients with cocaine-associated myocardial infarction. Ann Emerg Med. 1995 Dec;26(6):702-6.
30. Traub SJ, Hoffman RS, Nelson LS. Body packing: the internal concealment of illicit drugs. N Engl J Med. 2003 Dec 25;349(26):2519-26.
31. Heesch CM, Wilhelm CR, Ristich J, et al. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart. 2000 Jun;83(6):688-95.
32. Darke S, Kaye S, Duflou J. Comparative cardiac pathology among deaths due to cocaine toxicity, opioid toxicity, and non-drug-related causes. Addiction. 2006 Dec;101(12):1771-7.
33. Kolodgie FD, Wilson PS, Mergner WJ, et al. Cocaine-induced increase in the permeability function of human vascular endothelial cell monolayers. Exp Mol Pathol. 1999 Jun;66(2):109-22.
34. World Health Organization. mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings - version 2.0. 2016 [internet publication].
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台